 | • レポートコード：STR-DC043 • 出版社/出版日：Straits Research / 2019年11月28日 • レポート形態：英文、PDF、189ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：製薬 |
| Single User（1名様用、印刷不可） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User（5名様用） | ￥836,200 (USD5,650) | ▷ お問い合わせ |
| Enterprise Price（法人閲覧用） | ￥1,073,000 (USD7,250) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、動物用医薬品の世界市場について調査・分析し、調査手法、市場概要、疾患別（豚インフルエンザ、変形性関節症）分析、薬物別（豚薬、牛/反すう薬）分析、地域別分析、企業概要などを含め次の構成でお届け致します。 ・イントロダクション ・調査手法 ・市場概要 ・動物用医薬品の世界市場：疾患別（豚インフルエンザ、変形性関節症） ・動物用医薬品の世界市場：薬物別（豚薬、牛/反すう薬） ・動物用医薬品の世界市場：地域別 ・企業概要 |
The global veterinary pharmaceutical drug market was valued at USD 23,539 million in 2018 and is expected to grow at a CAGR of 5.5% during the forecast period, 2019–2026.
Veterinary pharmaceutical drugs are categorized into feed additives, vaccines, tablets and boluses, capsules, oral pastes and gels, drenches and tubing products, and topical dosage forms. These products are manufactured for various categories of animals including cattle, livestock, companion, and other animals. Growing number of favorable government regulations for animal health and welfare and increased consumption of pork and beef meat across the globe, are vital factors driving the global veterinary pharmaceutical drugs market.
Demand for dairy products is increasing year by year with rising population, which has ultimately escalated the demand for veterinary pharmaceutical drugs across the globe. Administering antibiotics to the poultry animals to keep them disease free is the common practice worldwide. According to the NATIONAL CHICKEN COUNCIL, in 2018, there were about 180 slaughter/evisceration plants for broiler chicken, which used more than 60 million tons of mixed feed. The U.S., being one of the leading broiler exporters across the globe, accounts for major share of the global veterinary pharmaceutical drugs market. Global 123 million tons of poultry production in 2018 demanded for high amount of veterinary pharmaceutical drugs, supporting the market growth.
The current global population is 7.7 billion and it is projected to reach 9.8 billion by 2050. The growing population will increase the demand for food, including meat, milk, eggs, and fish. Poultry is one of the fastest-growing agricultural sub-sectors and is likely to continue growing at a healthy CAGR. For instance, in 2018, the combined value of production from broilers, eggs, turkeys, and chickens was accounted for approximately USD 46.3 billion, up by 8% from USD 42.7 billion in 2017 in the U.S., the United States Department of Agriculture (USDA).
Segmental Insights
Global veterinary pharmaceutical drugs market is segmented by disease, drug types, sales channel, and region.
Based on disease, the market is segmented into swine influenza, osteoarthritis, newcastle disease, mastitis, and others. Swine influenza is a highly contagious viral infection in pigs. As of now, three subtypes of influenza A virus have been witnessed, namely A(H1N1), A(H1N2), and A(H3N2). It is dominant in North and South America, Europe and some parts of Asia and Africa. Disease outbreak influences industry growth, making swine influenza highest share grossing segment among disease. Osteoarthritis is a degenerative condition of the joints causing the joint to break down. As per Animal Friends Insurance research, Arthritis can cost pet owners around USD 3,293 a year. Newcastle disease (ND) is highly contagious and affects birds including poultry worldwide, especially in Africa, Asia, and South America. The major concern of Newcastle disease outbreak is its potential economic impact on the poultry industry. However, since wild birds can, sometimes, carry the virus without becoming ill, outbreaks can occur anywhere that poultry is raised. In California, its outbreak began in late 2002 and lasted until 2003. Foot and mouth disease (FMD), rabies, and other disease outbreaks impact biosecurity. This needs proper guidelines to prevent them from spreading further. Rabies is a preventable disease and is mostly found in raccoons, dogs, foxes, and other wild animals. rabies infection causes thousands of human deaths every year.
Based on drug types, the market is segmented into swine drug, cattle/ruminant drug, poultry drug, horse drug, pets (cats, dogs) drug, and other drug types. pets drug/companion animal drug segment, accounts for highest share among drug types.
Based on sales channel, the market is segmented into direct sales channel and indirect sales channel. In markets where manufacturers do not have direct commercial presence, offer products through distributors. Most of the companies in such regions offer their livestock and companion animal products through veterinarian. Apart from this, they provide products through local agricultural and farming retail outlets, pharmacies, and pet stores. For instance, Zoetis sells its products to veterinarians, third-party veterinary distributors, and retail outlets that then typically sell the products to livestock producers, making indirect sales channel segment highest share grosser among sales channel. The veterinary drug market is primarily driven by indirect sales, but in few cases, a direct sales channel is involved. For instance, Zoetis sells its livestock products directly to a wide range of livestock producers, including beef and dairy farmers, poultry and pork via distributors. Elanco is planning to expand its retail channels to meet the pet owner’s demands.
Regional Insights
Regionally, the global veterinary pharmaceutical drugs market is segmented into North America, Europe, Asia-Pacific, South America, Middle East and Africa.
North America dominates the global veterinary pharmaceutical drugs market. high number of companion animals, stringent government regulations regarding the health and safety of companion animals, and frequent outbreak of several animal diseases in the U.S., are some of the vital factors driving North America veterinary pharmaceutical drugs market. According to the American Society for the Prevention of Cruelty to Animals, around 6.5 million companion animals are registered and admitted to the U.S. animal shelters every year, out of which about 3.2 million are cats and 3.3 million are dogs. Moreover, after 2011, the companion animal adoption has increased significantly.
Europe accounts for optimum share of the global veterinary pharmaceutical drugs market.
Asia Pacific is expected to register fastest growth in the veterinary pharmaceutical drugs market. The region is housing a large population of cattle and a significant amount of people generates revenue from the meat of cattle, swine, and other animals. In addition, several governments in the region have imposed stringent regulations for the proper vaccination of the animals, which further drives the Asia Pacific veterinary pharmaceutical drug market. Rapidly expanding industry is expected to boost the demand for veterinary pharmaceutical drugs, fueling market growth. With increasing cattle breeding, market for veterinary pharmaceutical drugs in India is significantly growing.
South America accounts for significant share of the global market owing to the increasing poultry business.
The Middle East veterinary pharmaceutical drug market is holding a relatively low share of the global market. People in the Middle East rely on cattle and livestock animals except swine as their food source. Increasing consumption of beef, mutton, and chicken is expected to increase the demand for veterinary pharmaceutical drugs for obtaining disease-free meat through proper vaccination. Increasing awareness regarding animal health and rising incidences of animal disease outbreaks across the Middle East are expected to fuel the market growth.
Africa is expected to account for least share of the global veterinary pharmaceutical drugs market.
Key Players
Some of the major players in the veterinary pharmaceutical drugs market are, Boehringer Ingelheim International GmbH, Zoetis, Bayer AG, Elanco, Merck & Co. Inc., Virbac, Dechra Veterniary Products, Ceva, Vetoquinol India Animal Health Pvt. Ltd., Meiji Holdings Co., Ltd., Ourofino Saude Animal, Animalcare Group plc, and Parnell.
TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Veterinary Pharmaceutical Drug Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
3.5.1 Key Investments and Strategies
3.5.2 Market Entry Strategies
3.6 Competitive Landscape, 2019
3.6.1 Market Share Analysis, 2018
3.7 PESTEL Analysis
3.8 Pipeline Analysis
3.9 Patent Analysis
3.10 Comparison Between Patented and Generic Medicines
3.10.1 Cost Comparison
3.10.1.1 Patented Medicine
3.10.1.2 Generic Medicine
3.10.2 Product Availability
3.11 Effects of African Swine Fever
3.12 African Swine Fever Geographic Situation
4 By Disease Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Swine Influenza
4.2.1 Market Size & Forecast (Value)
4.3 Osteoarthritis
4.3.1 Market Size & Forecast (Value)
5 By Drug Type Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Swine Drug
5.2.1 Market Size & Forecast (Value)
5.3 Cattle/Ruminant Drug
5.3.1 Market Size & Forecast (Value)
6 Regional Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 America
6.2.1 North America
6.2.1.1 U.S.
6.2.1.1.1 By Disease
6.2.1.1.2 By Drug Type
6.2.1.2 Canada
6.2.1.2.1 By Disease
6.2.1.2.2 By Drug Type
6.2.1.3 Mexico
6.2.1.3.1 By Disease
6.2.1.3.2 By Drug Type
6.2.2. Latin America
6.2.2.1 By Disease
6.2.4.2 By Drug Type
6.3 Europe
6.3.1 Market Size & Forecast (Value)
6.3.2 Germany
6.3.2.1 By Disease
6.3.2.2 By Drug Type
6.3.3 France
6.3.3.1 By Disease
6.3.3.2 By Drug Type
6.3. 4 U.K
6.3.4.1 By Disease
6.3.4.2 By Drug Type
6.3.5 Italy
6.3.5.1 By Disease
6.3.5.2 By Drug Type
6.3.6 Spain
6.3.6.1 By Disease
6.3.6.2 By Drug Type
6.3.7 Rest of Europe
6.3.7.1 By Disease
6.3.7.2 By Drug Type
6.4 Asia Pacific
6.4.1 Market Size & Forecast (Value)
6.4.2 Japan
6.4.2.1 By Disease
6.4.2.2 By Drug Type
6.4.3 China
6.4.3.1 By Disease
6.4.3.2 By Drug Type
6.4.4 Australia
6.4.4.1 By Disease
6.4.4.2 By Drug Type
6.4.5 India
6.4.5.1 By Disease
6.4.5.2 By Drug Type
6.4.6 South Korea
6.4.6.1 By Disease
6.4.6.2 By Drug Type
6.4.7 Rest of Asia-Pacific
6.4.7.1 By Disease
6.4.7.2 By Drug Type
6.5 Middle East & Africa
6.5.1 Market Size & Forecast (Value)
6.5.2 Saudi Arabia
6.5.2.1 By Disease
6.5.2.2 By Drug Type
6.5.3 South Africa
6.5.3.1 By Disease
6.5.3.2 By Drug Type
6.5.4 Kuwait
6.5.4.1 By Disease
6.5.4.2 By Drug Type
6.5.5 Rest of Middle East & Africa
6.5.5.1 By Disease
6.5.5.2 By Drug Type
7 Company Profile
7.1 Boehringer Ingelheim International GmbH
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2 Zoetis
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3 Bayer AG
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 Elanco
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 Merck & Co. Inc.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 Virbac
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7 Dechra Veterniary Products
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio
7.8 Ceva
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Recent Developments
7.8.4 Product Portfolio
7.9 Vetoquinol India Animal Health Pvt. Ltd.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Recent Developments
7.9.4 Product Portfolio
7.10 Meiji Holdings Co., Ltd.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Recent Developments
7.9.4 Product Portfolio
7.11 Ourofino Saude Animal
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Recent Developments
7.9.4 Product Portfolio
7.12 Animalcare Group plc
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Recent Developments
7.9.4 Product Portfolio
TABLE 1 Global Veterinary Pharmaceutical Drug Market Share, By Disease, 2016–2026 ($Million)
TABLE 2 Swine Influenza Veterinary Pharmaceutical Drug Market Share, By Region, 2016–2026 ($ Million)
TABLE 3 Osteoarthritis Veterinary Pharmaceutical Drug Market Share, By Region, 2016–2026, ($ Million)
TABLE 4 Global Veterinary Pharmaceutical Drug Market Share, By Drug Type, 2016–2026 ($Million)
TABLE 5 Global Veterinary Pharmaceutical Drug Market through Swine Drug, By Region, 2016–2026 ($ Million)
TABLE 6 Global Veterinary Pharmaceutical Drug Market Share Value, 2016–2026 ($Million)
TABLE 7 America Veterinary Pharmaceutical Drug Market Share Value, By Country, 2016–2026 ($Million)
TABLE 8 America Veterinary Pharmaceutical Drug Market Share value, By Disease, 2016–2026 ($Million)
TABLE 9 America Veterinary Pharmaceutical Drug Market Share value, By Drug Type, 2016–2026 ($Million)
TABLE 10 U.S. Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 11 U.S. Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 12 Canada Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 13 Canada Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 14 Mexico Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 15 Mexico Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 16 Latin America Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 17 Latin America Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 18 Europe Veterinary Pharmaceutical Drug Market Share Value, By Country, 2016–2026 ($Million)
TABLE 19 Europe Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 20 Europe Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 21 Germany Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 22 Germany Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 23 France Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 24 France Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 25 UK Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 26 UK Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 27 Italy Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 28 Italy Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 29 Spain Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 30 Spain Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 31 Rest of Europe Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 32 Rest of Europe Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 33 Asia-Pacific Veterinary Pharmaceutical Drug Market Share Value, By Country, 2016–2026 ($Million)
TABLE 34 Asia-Pacific Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 35 Asia-Pacific Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 36 Japan Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 37 Japan Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 38 China Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 39 China Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 40 Australia Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 41 Australia Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 42 India Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 43 India Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 44 South Korea Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 45 South Korea Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 46 Rest of Asia-pacific Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 47 Rest of Asia-pacific Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 48 LAMEA Veterinary Pharmaceutical Drug Market Share Value, By Country, 2016–2026 ($Million)
TABLE 49 LAMEA Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 50 LAMEA Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 51 Saudi Arabia Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 52 Saudi Arabia Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 53 South Africa Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 54 South Africa Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 55 South Africa Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 56 Brazil Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 57 Brazil Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
TABLE 58 Rest of LAMEA Veterinary Pharmaceutical Drug Market share, By Disease, 2016–2026 ($Million)
TABLE 59 Rest of LAMEA Veterinary Pharmaceutical Drug Market share, By Drug Type, 2016–2026 ($Million)
List of Figures
FIGURE 1 Global Veterinary Pharmaceutical Drug Market Overview
FIGURE 2 Value Chain Analysis
FIGURE 3 Bargaining Power of Suppliers
FIGURE 4 Bargaining Power of Buyers
FIGURE 5 Threat of Substitutes
FIGURE 6 Threat of New Entrants
FIGURE 7 Competitive Rivalry
FIGURE 8 Veterinary Pharmaceutical Drug Market, Market Share Analysis, 2018
FIGURE 9 Global Veterinary Pharmaceutical Drug Market, 2016–2026
FIGURE 10 U.S. Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 11 Canada Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 12 Mexico Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 13 Germany Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 14 France Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 15 UK Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 16 Italy Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 17 Spain Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 18 REST OF EUROPE Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 19 Japan Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 20 China Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 21 Australia Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 22 India Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 23 South Korea Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 24 Rest of Asia-pacific Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 25 Saudi Arabia Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 26 South Africa Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 27 Brazil Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 28 Rest of LAMEA Veterinary Pharmaceutical Drug Market Share, 2016–2026 ($Million)
FIGURE 29 Boehringer Ingelheim International GmbH: Revenue Analysis, ($million)
FIGURE 30 Boehringer Ingelheim International GmbH: Segment Revenue 2018 (%)